Case Management

05-30-2017

9am-10am

5th Floor White Building

Dr. Catherine Najem

Target Audience

This program has been designed for physicians, fellows, residents, medical students in rheumatology.

Series Educational Objectives

After completing this activity, participants should be able to:

  • Improve preventive health care measures for patients with rheumatological diseases who are immunocompromised, such as vaccinations
  • Maintain clear practice in regards to screening and preventing medication toxicity in rheumatological disorders, such as antimalarial eye toxicity
  • Discuss and incorporate into clinical practice the latest guidelines in therapy for rheumatological disorders as well as optimal use of therapeutic agents, and counseling patients about fetal toxicity of some of the agents used in rheumatology

Accreditation

Physicians: The Perelman School of Medicine at the University of Pennsylvania is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation of Credit

Physicians: The Perelman School of Medicine at the University of Pennsylvania designates this live activity for a maximum of 1 AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

PAs: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 1 Category 1 credits for completing this activity.

Approved for (PSRM) patient safety/risk management designation

Acknowledgement of Commercial Support* NONE

For more information, please contact

Jennifer Fisher

215-662-2792

Disclosure of Relevant Financial Relationships and Unapproved Uses of Products

It is policy at the Perelman School of Medicine at the University of Pennsylvania and the Hospital of the University of Pennsylvania, Department of Nursing Education, Innovation and Professional Developmentfor individuals who are in a position to control the content of an educational activity to disclose to the learners all relevant financial relationships that they have with any commercial interest that provide products or services that may be relevant to the content of this continuing education activity. For this purpose we consider relationships of the person involved to include financial relationships of a spouse or partner.

The intent of this policy is to ensure that Penn CME/CNE certified activities promote quality and safety, are effective in improving medical practice, are based on valid content, and are independent of control from commercial interests and free of commercial bias. Peer review of all content was conducted for all faculty presentations whose disclosure information was found to contain relationships that created a conflict of interest relevant to the topic of their presentation. In addition, all faculty were instructed to provide balanced, scientifically rigorous and evidence-based presentations.

The staff in the Office of CME at the Perelman School of Medicine at the University of Pennsylvania, Mila Kostic, CHCP, FACEHP, Director of CME,Zalman Agus, MD,Senior peer reviewerand Patricia A. Smith, DPN, RN-BC,Nursing professional development specialist of the HUP Department of Nursing Innovation and Development have disclosed that they have norelevant financial relationships with any commercial interests related to the content of this educational activity.

The following individuals have disclosed that they have no relevant financial relationships with any commercial interests related to the content of this educational activity:

Planning Committee & Presenter Name

Chris Derk, MD / Anupama Shahane, MD

Presenter Name

Mugdha Agrawal / Joshua Baker / John Chadwick / Jonathan Dunham, MD
Joan Von Feldt, MD / Prateek C. Gandiga / Michael George / Sharon Kolasinski, MD
Colin LIgon, MD / Giorgos Loizidis / Carson Maynard / Tim Moore
Catherine Nagem / Rennie Rhee / Nora Sandorfi / AnnMarie Schorpion
Steffan Schultz / Preethi Thomas, MD

The following individuals have reported the listed relevant financial relationships with commercial interests related to the content of this educational activity.

Planning Committee member NameName of Commercial InterestRelationship

Alexis Ogdie Beatty, MDNovartis, PfizerConsultant & Co-Investigator

Peter Merkel, MDBMS, GSK, Chemocentryx, Celgene,GenentechInvestigator

Kypha, Astra-Zeneca, Terumo BCKInvestigator

Actelion, BMS, ProcipaBio, Sanoficonsultant

Chemocentryx, Genetech, GSK, Seattle Geneticsconsultant

Presenter NameName of Commercial InterestRelationship

Caria R. Scanzello BayerConsultant

Antoine Sreih, MDGenentech/Roche, Krogg and PartnersConsultant

Rupert Case Management and NaxionConsultant

Frederick Vivino, MDImmco Diagnostocs, Inc& Biogen IdecConsultant

Relevant financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received or expected

Disclosure of Unapproved Uses of Products: NONE